Pharmaceutical industry news

Is Tyra Biosciences, Inc. (TYRA) Stock a Biotech Opportunity Ahead of Key SURF302 Trial Data?

Is Syndax Pharmaceuticals, Inc. (SNDX) Stock Still a Biotech Opportunity After Revised AML Market Estimates?

Is Janux Therapeutics, Inc. (JANX) Stock a Biotech Opportunity With Next-Generation Immunotherapy Potential?

Unicycive turned away by FDA again over manufacturer’s plant shortfalls

Trinity Biotech’s AI cooling unit wins Open Compute Project backing

Crews respond to fire, hazmat situation at Cherry Hill pharmaceutical facility

Simplified C-glycosides synthesis could transform diabetes drug manufacturing

US FDA declines to approve Unicycive’s drug to treat elevated phosphate levels in dialysis patients

Unicycive shares plunge after FDA issues Complete Response Letter for kidney disease drug (UNCY)

Telitacicept Improves Clinical Response but Increases Infection and Hypogammaglobulinemia Risk in Adults with Active SLE: Phase 3 Trial Results

Telitacicept Improves Clinical Response but Increases Infection and Hypogammaglobulinemia Risk in Adults with Active SLE: Phase 3 Trial Results

Moleculin Biotech (NASDAQ: MBRX) raises $2.7M as 1.36M warrants are exercised

LB Pharmaceuticals names Christopher Zergebel as SVP By Investing.com

Candel Therapeutics initiates phase 3 lung cancer trial By Investing.com

FDA Issues CRL for Oxylanthanum Carbonate

Vistagen (NASDAQ: VTGN) Phase 3 fasedienol trial misses main goal but shows severe-SAD signal

Candel Therapeutics Announces Initiation of Global Pivotal Phase 3 AURORA Trial Evaluating Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors

FDA Seizes, Destroys Food Worth Rs 13.71 Lakh in Pune, Solapur Crackdown

Nauticus Robotics, Inc. has announced the completion of a debt restructuring agreement.

L’industrie pharmaceutique poursuit son engagement en faveur de l’insertion et de l’emploi des personnes en situation de handicap

Definium’s Phase 3 LSD Win Is Real. The Fracture It Exposed Is Bigger.

Candel opens global phase 3 AURORA trial in lung cancer

Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Stoke enrolls 162 patients in Phase 3 Dravet study

FDA hits Praxis with 3-month delay for epilepsy drug verdict

Delaware court throws out biotech IPO derivative suit

US FDA declines to approve Unicycive’s drug to treat elevated phosphate levels in dialysis patients

New Danish biotech company aims to turn new brain biology into business: "Now we'll see if we can make it fly"

Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors

Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)

Mag 7 Action Improves, But Biotech Keeps Delivering the Real Wins

Unicycive’s kidney drug hits FDA setback as label talks continue

Unicycive Therapeutics Receives Complete Response Letter

CORDIS project: HB-086 and HB-097 for Treatment of Chronic Sensory Neuronal Disorders - Neuropathic Pain and Hearing Loss

CORDIS project: Thalamic Nuclei Connectivity in the Psychosis Continuum: Parsing Clinical Heterogeneity and Individual Trajectories

BMS-backed Beeline 'putting worker bee mentality into effect' with $126M series A extension

Biotech ETF (BBC) Touches a New 52-Week High

FinancialContent - Sizzling Stocks Under $5: UPC, ANY, NNBR, DCOY Target AI Infrastructure, Data Centers, Pharmaceutical Innovation and Biotechnology Growth

Rats, cockroaches, rotting food: FDA suspends six Mumbai eateries in hygiene crackdown

Hazmat situation contained at Keystone Research and Pharmaceutical in Cherry Hill, New Jersey

India's First Homegrown Antibiotic Zaynich Gets US FDA Approval; Here's What You Need To Know About The Drug

Biotech ETF (BBC) Touches a New 52-Week High

India's First Homegrown Antibiotic Zaynich Gets US FDA Approval; Here's What You Need To Know About The Drug

Obesity drugs after the gold rush

BeOne's BRUKINSA cuts progression risk 43% in frontline lymphoma

Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study

Can Hansoh Pharmaceutical Monetize Its Expanding Drug Portfolio?

Mass. biotech IPO proceeds near $3.2B, close in on pandemic-era record pace

Salipro Biotech Announces Publication in Nature Scientific Reports on Expanding DEL Screening to Membrane Proteins

Lonza USA Eyes $1 Billion Clermont County Biotech Plant, Ohio

HLTH Europe 2026: Healthcare implementation key amid European innovation rush

UKHSA Evaluation Strategy

This Evaluation Strategy sets out UKHSA’s organisation‑wide approach to planning, conducting and usi...

Russia and Cuba set up first joint pharmaceutical venture

Price to book forward of PROTO SCRIPT PHARMACEUTICAL CORP – OTC:PSCR

Genomic Decision Support for Precision Medicine | Congenica

French biotech stock soars 40% after new data on experimental medicine

Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines

Joint Statement on Warning to Pharmacists About Diverted HIV Medicines Being Sold on Online Pharmacy-to-Pharmacy Platforms

FIRST AID: Biotech battle moves to Parliament

Towards an EU clinical trials competitiveness initiative: restoring Europe's edge